Collaboration for a Provincial Hospital Formulary: The New Brunswick Experience Faith Louis Regional Manager QI & Support, Pharmacy Services Horizon Health.

Slides:

Advertisements

Similar presentations

OUR CONTINUOUS JOURNEY TO EXCEPTIONAL. Mission Accomplished through CQIplus CQIplus helps us fulfill our mission, Through our Exceptional health care.

Advertisements

THE COMMONWEALTH FUND Developing Innovative Payment Approaches: Finding the Path to High Performance Stuart Guterman Vice President, Payment and System.

Medication Management

Back to the Drawing Board Summary of the work of the Human Services Redesign Committee from May 2012 forward.

November 26, Fall Forum Alberta’s Pharmaceutical Strategy and Programs Policy Recommendations.

Pricing and Reimbursement Policies 27. Pricing Policies Patented Medicines Patented Medicine Prices Review Board (PMPRB) monitors and sets the price of.

MEDICINES SELECTION & FORMULARY MANAGEMENT

1 CNAP Community Navigation and Access Program July 30, 2012.

The Laval University (Québec) virtual slide telepathology project; A structured patient-oriented network involving 21 sites Bernard Têtu MD, Medical director.

SEBs – A Public Payer Perspective

Montana University System URx: Rethinking our Rx program: A New Strategic Approach.

1 Collaboration Across the Spectrum of Formulary Decision-Making: From Hospitals to Health Authorities to Public Drug Plans CADTH 2015 Symposium Panel.

Addressing Fetal Alcohol Spectrum Disorder (FASD) in New Brunswick Stacy Taylor Department of Health January 24, 2012.

Coming Full Circle: AMI and Med Rec Across the Continuum. Western Node Collaborative Brandon Regional Health Authority Home Care Medication Reconciliation.

Background Pharmacy and Therapeutics Committees function at various levels to make formulary decisions Independent process resulting in variations in.

CADTH Therapeutic Reviews

The Canadian Top Ten Watch List of New and Emerging Health Technologies: Methods, Lessons Learned, and Impact Rosmin Esmail, MSc, CHE Chair for CNESH Director,

Collaboration Across the Spectrum of Formularies in Saskatchewan: The RQHR Perspective Wm. Semchuk, MSc,PharmD,FCSHP Manager, Pharmacy Practice Regina.

New Health Plan Strategies for Containing Medical Costs Leonard Davis Institute of Health Economics 2002/2003 Health Policy Seminar Series University of.

International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.

THE HOSPITAL AND THE DEPARTMENT OF PHARMACEUTICAL SERVICES.

A ntimicrobial S tewardship P rogramme I nnovation R esearch E ducation S afety Development and Implementation of a “Reserved Antimicrobial Drugs” (RAD)

1 Monitoring medical prescription in the Opole Voivodeship Branch of the NFZ Roman Kolek M.D.

Iowa Collaborative Safety Net Provider Network Pharmacy Initiative U of I School of Pharmacy Pharmaceutical Management For Underserved Population.

March 2015 is. PHARMACISTS: TRUSTED CARE WHEN AND WHERE YOU NEED IT.

PHAB Accreditation: What it means for Public Health April 8, 2015 CPHA Health Education Committee.

COMMUNITY MENTAL HEALTH SERVICES for the ELDERLY in RURAL MANITOBA COMMUNITY MENTAL HEALTH SERVICES for the ELDERLY in RURAL MANITOBA Parkland Regional.

Consultant Pharmacists

Report to Los Angeles County Executive Office And Los Angeles County Health Services Agencies Summary of Key Questions for Stakeholders February 25, 2015.

From Evidence to Action: Addressing Challenges to Knowledge Translation in RHAs The Need to Know Team Meeting May 30, 2005.

Anne Hiltz, Director Pharmacy and Renal Program Nova Scotia Health Authority.

Right Drug, Right Person, Right Price: Improving and Governing the Provincial Drug System Helen Stevenson Executive Lead, Drug System Secretariat Ministry.

EPharmacy Use Cases. Community focus Electronic Prescription Transfer GP-community pharmacy.

In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.

TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.

AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009 Health Information Technology for Economic and Clinical Health Act (HITECH Act) Regina.

NRI Survey on: Cooperation between universities and university hospitals On behalf of NRI: Lars Hvilsted Rasmussen Director of Research Aalborg University.

Supporting Informed Formulary Decision Making: CADTH’s Common Drug Review Denis Bélanger, Director, CADTH New Brunswick Stroke Summit November 27, 2010,

ASPECTS AFFECTING THE HOSPITAL OPERATION Financial Financial Operational Operational Administrative Administrative Clinical Clinical Safety Safety.

Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.

From Evidence to Action: Addressing the Challenges to Knowledge Translation in RHAs The Need to Know Team Meeting October 17, 2005.

A GP for Me -A GPSC Initiative 2015 Quality Forum Dr. Brenda Hefford- Executive Director, Practice Support and Quality, Doctors of BC Shana Ooms, Director,

How Aggressive Recruitment and Training of Pharmacists and Pharmacist’s Assistants is Being Utilized to Improve Management of Drug Supplies ICIUM CONFERENCE.

Office of Sponsored Projects The Funding Life Cycle.

Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*

Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.

MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.

1 Access to medicines for patients with mental health diseases within State Guarantee Benefit Programme in Talas and Batken regions of KG Makenbaeva B.

Connecting for a health-e-future Dr Brian Richards National Director E-Health Implementation Department of Health and Aging.

IMPROVING ECONOMIC PRESCRIBING IN A TEACHING HOSPITAL THROUGH AN EDUCATIONAL STRATEGY TO PROMOTE GENERIC PRESCRIBING.

An Employer Perspective Moosehead Breweries Ltd. Mike Lee Vice President – Human Resources.

ICRM Peer Review Feedback and Planning Presentation Presenter: Ms Maneo Dichaba Date: 21 April 2016.

New Drug Approval on Prince Edward Island Iain Smith and Amanda Burke CADTH Symposium, Ottawa, ON

Inter-professional Collaborative & Learning Environments Project: an Overview.

Expanding the Reach of Evidence in Nova Scotia Can we get the Evidence to Everyone? CADTH Symposium 2016 Lisa Farrell- Chair of DEANS ( NS Liaison CADTH)

A lens to ensure each student successfully completes their educational program in Prince Rupert with a sense of hope, purpose, and control.

Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.

Annie Bilodeau Executive Director. Disclosure No conflict of interest.

Cancer Drug Funding Sustainability: From Recommendations to Action CADTH SYMPOSIUM 2016 Scott Gavura, Director, Provincial Drug Reimbursement Programs.

Formulary Manufacturer Contracting Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.

Starting Medication Abortion Services in a FQHC Residency Clinic: You Can Do It! Lealah Pollock, MD, MS Isabel Lee, MD UCSF Family and Community Medicine.

REDESIGNING ORGANIZATION & MANAGEMENT SYSTEMS (IHSDNs Attributes # 7, 8, 9,10, 11, 12, 13) (IHSDNs Attributes # 7, 8, 9,10, 11, 12, 13) July , 2015.

Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia.

Patient Voices Network

Therapeutic Drug Management Quality Project

Action Plan 1: 2017 – 2020 For Information Only.

A LONGITUDINAL POLICY ANALYSIS OF THE IMPACT ON PRESCRIBING PATTERNS AND MEDICATION COST OF A GENERIC DISPENSING POLICY IN A TEACHING HOSPITAL IN THAILAND.

Formulary Manufacturer Contracting

How can we make healthcare purchasing in Kenya more strategic?

Will Seavey PharmD, BCPS MSHP Treasurer

Presentation transcript:

Collaboration for a Provincial Hospital Formulary: The New Brunswick Experience Faith Louis Regional Manager QI & Support, Pharmacy Services Horizon Health Network April 13, 2015

Speaker Disclosure Presenter has no real or potential conflicts to disclose

Background – New Brunswick Population: 754,524 Only official bilingual province 2 Regional Health Authorities (RHAs) – Vitalité & Horizon 22 hospitals (small rural to large tertiary care site) 2013/2014 RHA Drug Expenditure: $70,848,457 (previous year - $71,138,716) Regionalization in Sept 2008 (8 to 2 RHAs) Provincial Health Plan 2009 –Included single provincial hospital formulary Provincial Drugs & Therapeutics committee (D&T) launched in Fall 2010 –Single committee structure with representation and support from both RHAs; universal decision binding to all hospital sites; single provincial hospital formulary

Areas of Collaboration with Provincial Pharmaceutical Services New Brunswick Department of Health, Pharmaceutical Services underwrites and administratively supports Provincial D&T –Meeting costs, per diems for physicians, admin support, translation, SharePoint collaborative site Personnel supporting NB Prescription Drug Plan (NBPDP) sit at main D&T committees/working groups and share information with RHA team –Status of medications under evaluation by D&T with NBPDP including restrictions, existence of price listing agreements (PLAs), upcoming reviews or changes at NBPDP Regular bi-weekly teleconferences between Executive Director, Department of Health, Pharmaceutical Services Branch, RHA Directors of Pharmacy, and Secretary of D&T (forms D&T secretariat)

Speaker Perspective Regional Manager of Quality Improvement and Support Services, Pharmacy, Horizon Health Network Pharmacist Manager in Regional Health Authority (RHA) Hospital perspective Principal Secretariat for NB Provincial Drugs and Therapeutics committee (D&T) Act as secretary for Provincial D&T working with RHA Directors of Pharmacy and Executive Director, Department of Health, Pharmaceutical Services Branch Provincial mandate & scope (Provincial Hospital Formulary)

Decision Making Process Representation at all levels by both RHAs (committee/subcommittee/working groups) –Provincial stakeholder feedback process –Subcommittees vet evaluations and submitted information: make recommendations to D&T –Decisions at D&T by majority vote (use electronic voting) Considerations –evidence informed approach Includes consideration of CADTH evaluations and reports, The Institut national d’excellence en santé et en services sociaux (INESSS) recommendations, NBPDP status –Seamless Care between hospitals and between hospital and community after discharge

Opportunities and Challenges Opportunities –Greater alignment between hospitals and publicly funded provincial outpatient drug program –Seamless Care between hospitals as well as between hospital & community post discharge –Better use of resources (financial, HR); potential for cost savings with better overall formulary management Challenges –What works in community doesn’t always work in hospitals and vice versa –Delays in decisions to allow alignment of formulary listings E.g. dabigatran, ticagrelor, chemotherapy agents

Rewards Major provincial initiative –great buy-in –closer working relationship and alignment with publicly funded provincial drug program –greater alignment of formulary listings between hospital and community and continuity of care post discharge Higher level of practice –evidence informed approach –degree of scrutiny is higher/expectations are higher –consolidation of human resources

Thank You